Pulse Biosciences, Inc. PLSE
Set alert
52.24 USD -3.24 -5.84%
At close · Oct 30
52.00 -0.24 -0.46%
After hours · Oct 30, 4:48 PM ET
51.39 Day range 54.70
12.66 52-week range 55.48
- YTD
- +280.48%
- 1 year
- +209.11%
- Open
- 54.33
- Prev close
- 55.48
- Mkt cap
- 3.73B
- Vol
- 466.45K
- Avg vol
- 500.48K
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 51.39
- High
- 54.70
- Forward P/E
- -44.65
- Beta
- 1.57
- Short ratio
- 5.88
- Inst. own
- 15.32%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 50.99
- 200-d avg
- 31.16
- 1y target
- 62.33
2Y chart
Events in this range
- Aug 12, 2025Earnings: -0.28; estimate -0.26; surprise -7.69%
- Nov 5, 2025Earnings: -0.29; estimate -0.31; surprise 6.45%
- Feb 19, 2026Earnings: -0.26; estimate -0.265; surprise 1.89%
- May 4, 2026Earnings: -0.27; estimate -0.32; surprise 15.62%
- Aug 6, 2026Earnings: -0.36; estimate -0.31; surprise -16.13%
- Aug 10, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 17, 2026Rating: Needham · — → Buy
- Sep 9, 2026Rating: Freedom Capital Markets · — → Buy
- Sep 23, 2026Rating: BTIG · — → Buy
- Oct 6, 2026Rating: Canaccord Genuity · Buy → Buy
- Oct 13, 2026Rating: Oppenheimer · Outperform → Outperform
Signals (103)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 3, 2026 | 1 month ago |
| RSI: Overbought | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| RSI: Overbought | Aug 3, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| RSI: Overbought | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 1, 2026 | 6 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 7, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 7, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 26, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| RSI: Overbought | Feb 17, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| RSI: Overbought | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 5, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 4, 2026 | 8 months ago |
| SMA: Bearish | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 16, 2026 | 9 months ago |
| SMA: Bearish | Jan 15, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 15, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 19, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 1, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 13, 2025 | 1 year ago |
| RSI: Overbought | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 29, 2025 | 1 year ago |
| SMA: Bullish | Aug 13, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 11, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 7, 2025 | 1 year ago |
| SMA: Bearish | Jun 11, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| SMA: Bearish | Jun 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 5, 2025 | 1 year ago |
| MACD: Buy Signal | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| MACD: Buy Signal | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| MACD: Sell Signal | May 5, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Apr 30, 2025 | 1 year ago |
| SMA: Bullish | Apr 22, 2025 | 1 year ago |
| SMA: Bearish | Apr 21, 2025 | 1 year ago |
| SMA: Bullish | Apr 17, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 28, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| SMA: Bullish | Feb 25, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 14, 2025 | 1 year ago |
| RSI: Overbought | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 23, 2025 | 1 year ago |
| SMA: Bullish | Jan 21, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
Key statistics
- Market cap
- 3.73B
- Enterprise value
- 3.86B
- Trailing P/E
- 0.00
- Forward P/E
- -44.65
- PEG ratio
- 0.00
- Price / sales
- 3144.21
- Price / book
- 37.18
- EPS (TTM)
- -1.18
- Beta
- 1.57
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 1.19M
- Revenue growth
- 0.00%
- Free cash flow
- -34.29M
- Total cash
- 101.62M
- Total debt
- 6.77M
- Return on equity
- -78.49%
- Shares outstanding
- 71.32M
- Short % of float
- 14.09%
- 50-day average
- 50.99
- 200-day average
- 31.16
Analyst view
Consensus: none
Price target (mean) 62.33 +19.3% upside
Now 52.24
- Target (low)
- 55.00
- Target (mean)
- 62.33
- Target (high)
- 73.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate -0.2875.
Financials — quick view
PLSE Revenue — quarterly 434.00K
PLSE Net income — quarterly -24.66M
PLSE EPS — quarterly -0.36
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | -0.3095 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | -0.31 | -0.36 | -0.05 | -16.13% |
| May 4, 2026 | Mar 31, 2026 | -0.32 | -0.27 | +0.05 | +15.62% |
| Feb 19, 2026 | Dec 31, 2025 | -0.265 | -0.26 | +0.01 | +1.89% |
| Nov 5, 2025 | Sep 30, 2025 | -0.31 | -0.29 | +0.02 | +6.45% |
| Aug 12, 2025 | Jun 30, 2025 | -0.26 | -0.28 | -0.02 | -7.69% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 6, 2026 | Canaccord Genuity | main | Buy | Buy |
| Sep 23, 2026 | BTIG | init | — | Buy |
| Sep 9, 2026 | Freedom Capital Markets | init | — | Buy |
| Aug 17, 2026 | Needham | init | — | Buy |
| Aug 10, 2026 | Canaccord Genuity | main | Buy | Buy |
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- pulsebiosciences.com
News
- Pulse Biosciences to Present at Stifel 2026 Healthcare Conference
- Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026
- Varex Imaging (NASDAQ:VREX) vs. Pulse Biosciences (NASDAQ:PLSE) Head to Head Review
- Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
- Pulse Biosciences Partners With Clayman Thyroid Center At Hospital For Endocrine Surgery In Tampa, Florida
- Pulse Biosciences Announces Commercial and Clinical Partnership with the Clayman Thyroid Center
- Oppenheimer Maintains Outperform on Pulse Biosciences, Raises Price Target to $60
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pulse Biosciences' nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026
- Pulse Biosciences Achieves Enrollment Target in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Treatment
Your note
Sign in to keep a note on PLSE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRETT BURKE T | Former | Sale | Dec 10, 2024 | 63,172 |
| DANAHY KEVIN PATRICK | Officer | Conversion of Exercise of derivative security | Feb 17, 2026 | 43,298 |
| DUGGAN ROBERT WILLIAM | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | May 10, 2026 | 49,291,700 |
| LAVIOLETTE PAUL A | Chief Executive Officer | Purchase | May 10, 2026 | 15,846 |
| UECKER DARRIN R | Chief Technology Officer | Conversion of Exercise of derivative security | Sep 16, 2025 | 284,406 |
| ZANGANEH MAHKAM | Director | Conversion of Exercise of derivative security | Feb 2, 2025 | 873,469 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 2.07% | 1,466,702 | 76.62M | Jun 29, 2026 |
| Bank of America Corporation | 2.04% | 1,446,611 | 75.57M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 1.11% | 788,640 | 41.20M | Jun 29, 2026 |
| Portolan Capital Management, LLC | 1.06% | 753,333 | 39.35M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 1.06% | 748,638 | 39.11M | Jun 29, 2026 |
| Balyasny Asset Management LP | 1.01% | 718,103 | 37.51M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.78% | 554,612 | 28.97M | Jun 29, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 0.69% | 485,300 | 25.35M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.69% | 489,643 | 25.58M | Sep 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers U.S. Total Stock Fd. | 0.49% | 343,542 | 17.95M | Aug 30, 2026 |
| MFS SERIES TRUST I-MFS New Discovery Fund | 0.48% | 339,453 | 17.73M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 0.30% | 215,880 | 11.28M | Jun 29, 2026 |